Press release
Bioengineered Protein Drugs for Cancer Treatment Market to Grow at CAGR of 7% Through 2025
Pharmaceutical and biotechnological companies are the leading end users in the bioengineered protein drugs market, as these companies constantly strive to increase the exclusivity to their portfolios. Collectively, these end users are projected to account for 53% of the market share by 2025. However, a shift from in-house R&D towards outsourced services is augmenting the importance of contract research organisations as end users in the bioengineered protein drugs market.Click here to Get Synopsis of the Report – https://www.factmr.com/report/4440/bioengineered-protein-drugs-market
Increasing reliance on these organisations for drug discovery portends the growing adoption of bioengineered protein drugs to further improve their efficacy. In addition, governments of developed regions have extended financial aid to reduce the mortality rate, which is further likely to strengthen the pathway for the penetration of bioengineered protein drugs. Though the overall market movement looks prodigious, an analytical study published by Fact.MR foresees the advent of generic drugs as an impeder to the growth of the global bioengineered protein drugs market.
Key Highlights of Bioengineered Protein Drugs Market
• Patients suffering from cancer continue to remain the target audience of players in the bioengineered protein drugs market. Adoption of bioengineered protein drugs for treatment is projected to increase at a CAGR of around 7% during the forecast period (2020-2025). Also, a spurt in the sales of these drugs is expected, which is likely to be driven by individuals diagnosed with infectious diseases.
For detailed insights on enhancing your product footprint, request for a sample here - https://www.factmr.com/connectus/sample?flag=S&rep_id=4440
• High costs associated with bioengineered protein drugs, in tandem with their short shelf life, causes reluctance among patients towards their adoption. In addition, increasing development of biosimilar products that cost just 20% of branded drugs is expected to deter revenue potential of the bioengineered protein drugs market during the forecast period.
• Preference for oral route of drug administration for any medication is high among patients, on the back of convenience and ease. However, bioengineered protein drugs are difficult to administer in an oral formulation, on account of gastric acid formed in the stomach, which could impede their adoption rate.
A subject matter expert at Fact.MR opines, “The healthcare industry is experiencing a shift from curative care towards preventive care, which is projected to create more sales prospects for bioengineered protein vaccines over therapeutic proteins.”
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4440
Prominent Players Rely on Generic Drugs and Strong Distribution Network
F.Hoffmann-La Roche, AbbVie, and Johnson & Johnson are the leading players, collectively accounting for around 60% share in the global bioengineered protein drugs market. The focal point of these players is on the development of branded drugs to treat myriad rare diseases. A substantial revenue of F.Hoffmann-La Roche is attributable to its blockbuster drugs - Avastin, Rituxan, and Herceptin, specifically developed for the treatment of cancer. Another leading player, AbbVie, holds a dominant position in the bioengineered protein drugs market, on account of its flagship product-Humira-which is considered as a breakthrough product to treat a number of conditions and diseases.
For in-depth competitive analysis, buy now - https://www.factmr.com/checkout/4440/S
In contrast to the focus of leading players on the development of branded drugs, prominent and emerging players strive to ace the market race through generic formulations. Also, they take measured actions towards strengthening their distribution network to increase the accessibility of their products.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/4440/bioengineered-protein-drugs-market
Content Source: https://www.factmr.com/media-release/1223/global-bioengineered-protein-drugs-market
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bioengineered Protein Drugs for Cancer Treatment Market to Grow at CAGR of 7% Through 2025 here
News-ID: 2271975 • Views: …
More Releases from Fact.MR
Managed Security Services Market is Projected to Reach USD 93.72 Billion by 2034 …
The global managed security services (MSS) market is estimated at USD 27.85 billion in 2024 and is projected to increase at a remarkable CAGR of 12.9% to reach a value of USD 93.72 billion by the end of 2034. This expansion is driven by the escalating cyber threats, regulatory compliance requirements, and the growing complexity of IT environments. Managed security services provide outsourced monitoring and management of security devices and…
Magneto Resistive RAM Market is Estimated to Reach USD 7.25 Billion by 2034 | Ke …
Magneto Resistive RAM Market is estimated at USD 650.9 million in 2024 and is projected to grow at a CAGR of 27.3%, reaching USD 7.25 billion by 2034. This explosive expansion is driven by MRAM's superior attributes, including high-speed access, compact size, and resilience, making it ideal for edge computing, IoT devices, and applications requiring data durability. MRAM is increasingly replacing traditional flash and DRAM due to its scalability, density,…
Scalp Health Market is Forecasted to Reach USD 18.4 Billion by 2035 | Fact.MR Re …
Scalp Health Market is projected to reach USD 18.4 billion by 2035, rising from USD 9.6 billion in 2025, with a projected CAGR of 6.7% during the forecast period. This shift signifies a critical evolution in consumer behavior - one where the scalp is no longer viewed as a peripheral concern within haircare but as a standalone health domain intersecting dermatology, neurocosmetics, and preventative wellness. Driven by rising awareness of…
Basal Insulin Market is Projected to Reach USD 44,659 Million by 2035 | Key Play …
The global basal insulin market is expected to reach USD 44,659 million by 2035, up from USD 18,893 million in 2024. During the forecast period 2025 to 2035, the industry is projected to register at a CAGR of 8.3%, driven by the increasing burden of Type 2 diabetes, patient-friendly once-daily dosing, and advancements in long-acting analogs such as degludec and glargine. Enhanced delivery technologies, robust R&D, and expanding global diabetes…
More Releases for Unit
Global Transcutaneous Electrical Nerve Stimulation Unit Market, Transcutaneous E …
Global Transcutaneous Electrical Nerve Stimulation Unit Market Overview:
The Transcutaneous Electrical Nerve Stimulation Unit market is a broad category that includes a wide range of products and services related to various industries. This market comprises companies that operate in areas such as consumer goods, technology, healthcare, and finance, among others.
In recent years, the Transcutaneous Electrical Nerve Stimulation Unit market has experienced significant growth, driven by factors such as increasing consumer demand,…
Glycol Dehydration Unit Market Glycol Dehydration Unit Market 2028
Persistence Market Research delivers key insights on the global glycol dehydration unit market, in its report titled, 'Glycol Dehydration Unit Market: Global Industry Analysis 2013-2017 and Forecast 2018-2028'. Over the forecast years, the global glycol dehydration unit market is expected to show a positive outlook.
The market value is expected to increase at a healthy pace over the forecast period. Based on the glycol type segment, the triethylene glycol segment is…
Biodiesel Processing Unit
While reserves of petroleum are decreasing every passing day, energy consumption is increasing at 6.5% per annum. And for solving this issue many countries are implementing new policies for minimizing the usage of fossil fuels and increase the use of alternative sources like solar power and Biodiesel. Biodiesel is a diesel fuel substitute made from a variety of oils, fats, and greases which can become a cheaper alternative to fossil…
Jackfruit Processing Unit
The fruit processing sector has some undoubtedly potential Business Ideas, and Jackfruits processing is highly recommended because jackfruits are highly perishable tropical fruits, which helps in improving the immunity, replenishes the energy, cardiovascular health, regulates Blood Pressure, Digestion, treats the skin diseases, prevent/control asthma and many more awesome advantages of jackfruit consumption.
Rising demand for processed fruit product for secondary preparations, rising income, and resultant increased spending on food items is…
Pomegranate Processing unit
India is the second largest producer of Pomegranates in the world after Iran, still contributes only 5% pomegranate related international trades. India produces the finest edible Pomegranates, which are available almost throughout the year, which provides a tremendous potential for export of Pomegranate and its products from India.
Processing of the Pomegranates becomes essential in order to increase the utilization and reduce the wastage of the fruit. Pomegranates being rich in…
Coconut Processing Unit
Coconut is an important fruit in the Indian economy as the country is listed among the top Coconut producing countries in the world. The contribution of Coconut is about ₹27900 crore to India’s Gross Domestic Product (GDP).
Today's improved economic stability, spending power, nutritional requirements, and awareness are pushing consumers to shift their preferences.
Currently, Coconut water, Coconut milk/cream and Virgin Coconut Oil (VCO) are expected to be main growth drivers for…
